DEESIDE, Wales, July 25, 2014 /PRNewswire/ -- ConvaTec, a leading global medical products and technologies company, today announced that its UnoMeter™ Safeti™ Plus portfolio of hourly diuresis systems is now free of DEHP. The company now offers its major Continence & Critical Care brands in DEHP-free design, including the Flexi-Seal™ Fecal Management System and the AbViser™ AutoValve™ Intra-Abdominal Pressure Monitoring Device.
ConvaTec is replacing DEHP in all its products, an effort well underway with completion expected in 18 months.
DEHP has been widely used in the medical device industry to soften PVC into a flexible material that can be used in such medical applications as enteral feeding, wound drainage and airway ventilation. However, concerns have been raised about potentially harmful effects associated with its use.
ConvaTec will replace DEHP with DEHT, an alternative, safe plasticizer that is widely used in children's toys and beverage closures.
"We are pleased to be an industry leader in going DEHP-free," said Steve Bishop, Vice President of Research & Development at ConvaTec. "This underscores our continued commitment to patient and environmental safety."
For more information, http://www.convatec.com/continence-critical-care/convatec-goes-dehp-free.
ConvaTec is a global medical products and technologies company, with leading market positions in wound therapeutics, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. ConvaTec has over 8,000 employees, with 11 manufacturing sites in 8 countries, and we do business in more than 100 countries. We are owned by Nordic Capital and Avista Capital Partners. More information is available at www.convatec.com.
®/™ indicates trademarks of ConvaTec Inc.
© 2014 ConvaTec Inc.
For additional reference/background:
References available upon request.